Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RE-COVER II
2007-002631-86Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in venous thromboembolism (VTE), deep vein thrombosis (DVT) and pulmonary embolism (PE) comparing Dabigatran etexilate with Warfarin (2 arms). Started Apr 2008; status: completed.
02
Drugs
dabigatranwarfarin
03
Conditions
venous thromboembolism (VTE)deep vein thrombosis (DVT)pulmonary embolism (PE)
Beyond the preview
Go deeper on 2007-002631-86.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002631-86.